X-linked Agammaglobulinemia is rare primary immunodeficiency disorder. X-linked Agammaglobulinemia is caused by a mutation on the BTK gene, the gene that is responsible for making B-cells, the cells that later develop into antibodies. As a result of this mutation and the lack of antibodies, people with X-linked Agammaglobulinemia are unable to fend off infections. Because it is an X-linked disease, the majority of people who have X-linked Agammaglobulinemia are men and are diagnosed with the disease when they are babies. Although there is no cure for the disease, treatment options such as immunoglobin replacement therapy and heavy antibiotic use are available.
X-linked Agammaglobulinemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on X-linked Agammaglobulinemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 3029 products for the study of X-linked Agammaglobulinemia that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
X-linked Agammaglobulinemia is also known as Agammaglobulinemia, Btk, Bruton Type Agammaglobulinemia, Bruton's Agammaglobulinaemia, Bruton's Agammaglobulinemia, Bruton's Hypogammaglobulinemia.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.